Background. To minimize the side effects of treatment in children with
Hodgkin's disease (HD), chemotherapy was given without radiotherapy.
Patients and methods: From 1975 to 1984, 21 patients with HD having ly
mph nodes <4 cm were treated with six MOPP courses. From 1984 to 1987,
all children presenting with HD (n = 17) were given six ABVD courses.
From 1987 to 1993 all children (it = 21) were treated with six altern
ating ABVD and MOPP courses. Results. MOPP-treated children showed an
event-free survival (EFS) of 91%, overall survival, 100%; ABVD-treated
children had an EFS of 70%, overall survival, 94%; ABVD-MOPP-treated
children had an EFS of 91% and an overall survival of 91%. Two cases d
eveloped a second malignancy. Toxicity was low. Conclusions: In childr
en, ABVD-MOPP treatment gives a good survival, and toxicity is low. Ra
diotherapy is not needed to treat HD in children.